AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 132 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $97 | -72.6% | 22,986 | -79.9% | 0.01% | -77.1% |
Q2 2023 | $354 | +216.1% | 114,251 | +41.9% | 0.04% | +218.2% |
Q1 2023 | $112 | -67.8% | 80,519 | -54.0% | 0.01% | -74.4% |
Q4 2022 | $348 | -99.9% | 175,049 | +15.3% | 0.04% | -40.3% |
Q2 2022 | $483,000 | +7.3% | 151,865 | +40.6% | 0.07% | +20.0% |
Q1 2022 | $450,000 | +181.2% | 107,974 | +223.3% | 0.06% | +200.0% |
Q4 2021 | $160,000 | -71.9% | 33,402 | -70.0% | 0.02% | -68.8% |
Q2 2021 | $569,000 | +240.7% | 111,200 | +347.2% | 0.06% | +128.6% |
Q1 2021 | $167,000 | -7.7% | 24,867 | -37.1% | 0.03% | -6.7% |
Q4 2020 | $181,000 | -13.4% | 39,552 | -26.6% | 0.03% | -14.3% |
Q3 2020 | $209,000 | -12.2% | 53,864 | +7.9% | 0.04% | -73.7% |
Q2 2020 | $238,000 | -30.4% | 49,901 | -49.2% | 0.13% | +54.7% |
Q1 2020 | $342,000 | -7.1% | 98,239 | +91.6% | 0.09% | +109.8% |
Q2 2019 | $368,000 | +56.6% | 51,264 | +195.6% | 0.04% | +51.9% |
Q4 2018 | $235,000 | – | 17,343 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 19,552,001 | $433,859,000 | 20.80% |
BRIDGER MANAGEMENT, LLC | 2,642,621 | $58,640,000 | 3.39% |
TPG Group Holdings (SBS) Advisors, Inc. | 3,884,600 | $86,199,000 | 1.10% |
HUSSMAN STRATEGIC ADVISORS, INC. | 125,000 | $2,774,000 | 0.80% |
HealthCor Management, L.P. | 1,036,110 | $22,991,000 | 0.76% |
GW&K Investment Management, LLC | 2,049,765 | $45,484,000 | 0.73% |
Bridge City Capital, LLC | 50,434 | $1,119,000 | 0.70% |
TCW GROUP INC | 2,521,064 | $55,942,000 | 0.46% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 2,876,367 | $63,827,000 | 0.41% |
Quadrant Capital Management, LLC | 25,002 | $555,000 | 0.35% |